Security key
868459108
SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN)
CUSIP: 868459108
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 57,671,650
- Total 13F shares
- 56,959,606
- Share change
- -424,903
- Total reported value
- $1,570,365,603
- Put/Call ratio
- 8.6%
- Price per share
- $27.57
- Number of holders
- 235
- Value change
- -$13,068,601
- Number of buys
- 100
- Number of sells
- 120
Report period
Q3 2023
Institutions
235
Top holders
10
SUPN full security history
Newer quarter: Q4 2023
Previous quarter: Q2 2023
SUPERNUS PHARMACEUTICALS, INC. SEC filings
SUPERNUS PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 868459108
Recent filing periods:
Top shareholders of SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
17%
|
9,960,423
|
$299,410,317 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
10%
|
6,043,469
|
$181,666,679 | — | 30 Jun 2023 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
8.7%
|
5,036,000
|
$151,382,160 | — | 30 Jun 2023 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
4.3%
|
2,503,458
|
$75,254,000 | — | 30 Jun 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
4.2%
|
2,430,916
|
$73,073,115 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
3.2%
|
1,869,292
|
$56,190,918 | — | 30 Jun 2023 | |
| Stephens Investment Management Group LLC |
13F
|
Company |
2.9%
|
1,700,715
|
$51,123,493 | — | 30 Jun 2023 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
2.8%
|
1,593,305
|
$47,895,000 | — | 30 Jun 2023 | |
| Polar Capital Holdings Plc |
13F
|
Company |
2.6%
|
1,504,470
|
$45,224,368 | — | 30 Jun 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.6%
|
1,496,322
|
$44,979,000 | — | 30 Jun 2023 | |
| GW&K Investment Management, LLC |
13F
|
Company |
2.4%
|
1,399,255
|
$42,062,000 | — | 30 Jun 2023 | |
| Aristotle Capital Boston, LLC |
13F
|
Company |
2%
|
1,161,947
|
$34,928,115 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
1,054,146
|
$31,687,638 | — | 30 Jun 2023 | |
| ASHFORD CAPITAL MANAGEMENT INC |
13F
|
Company |
1.6%
|
926,111
|
$27,838,897 | — | 30 Jun 2023 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
1.3%
|
777,962
|
$23,385,538 | — | 30 Jun 2023 | |
| CONGRESS ASSET MANAGEMENT CO |
13F
|
Company |
1.3%
|
770,059
|
$23,147,974 | — | 30 Jun 2023 | |
| Invesco Ltd. |
13F
|
Company |
1.3%
|
747,482
|
$22,469,309 | — | 30 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.3%
|
735,588
|
$22,111,775 | — | 30 Jun 2023 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.1%
|
658,701
|
$19,800,552 | — | 30 Jun 2023 | |
| Bellevue Group AG |
13F
|
Company |
1.1%
|
650,256
|
$19,546,695 | — | 30 Jun 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1%
|
595,225
|
$17,892,464 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.96%
|
555,898
|
$16,710,294 | — | 30 Jun 2023 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.96%
|
554,793
|
$16,677,081 | — | 30 Jun 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.94%
|
542,508
|
$16,307,791 | — | 30 Jun 2023 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.91%
|
523,500
|
$15,736,410 | — | 30 Jun 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.89%
|
513,004
|
$15,422,000 | — | 30 Jun 2023 | |
| Epoch Investment Partners, Inc. |
13F
|
Company |
0.83%
|
476,039
|
$14,309,732 | — | 30 Jun 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.79%
|
458,020
|
$13,768,081 | — | 30 Jun 2023 | |
| Pacer Advisors, Inc. |
13F
|
Company |
0.78%
|
448,995
|
$13,496,790 | — | 30 Jun 2023 | |
| Tributary Capital Management, LLC |
13F
|
Company |
0.6%
|
348,240
|
$10,468,094 | — | 30 Jun 2023 | |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.6%
|
347,885
|
$10,457,423 | — | 30 Jun 2023 | |
| NORGES BANK |
13F
|
Company |
0.59%
|
340,647
|
$10,239,849 | — | 30 Jun 2023 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.55%
|
317,596
|
$9,546,936 | — | 30 Jun 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.52%
|
302,677
|
$9,098,470 | — | 30 Jun 2023 | |
| SCOUT INVESTMENTS, INC. |
13F
|
Company |
0.51%
|
295,158
|
$8,910,820 | — | 30 Jun 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.5%
|
288,306
|
$8,666,478 | — | 30 Jun 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.48%
|
279,400
|
$8,398,764 | — | 30 Jun 2023 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.47%
|
268,725
|
$8,077,463 | — | 30 Jun 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.45%
|
257,226
|
$7,732,214 | — | 30 Jun 2023 | |
| S&T BANK/PA |
13F
|
Company |
0.38%
|
221,243
|
$6,651,000 | — | 30 Jun 2023 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.35%
|
202,653
|
$6,091,749 | — | 30 Jun 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.33%
|
191,173
|
$5,746,660 | — | 30 Jun 2023 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.33%
|
190,179
|
$5,716,781 | — | 30 Jun 2023 | |
| BURNEY CO/ |
13F
|
Company |
0.32%
|
186,359
|
$5,601,944 | — | 30 Jun 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.29%
|
164,578
|
$4,947,214 | — | 30 Jun 2023 | |
| Phocas Financial Corp. |
13F
|
Company |
0.27%
|
157,216
|
$4,726,000 | — | 30 Jun 2023 | |
| Legal & General Group Plc |
13F
|
Company |
0.27%
|
154,252
|
$4,636,815 | — | 30 Jun 2023 | |
| CW Advisors, LLC |
13F
|
Company |
0.26%
|
152,644
|
$4,588,476 | — | 30 Jun 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.25%
|
141,684
|
$4,259,021 | — | 30 Jun 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.23%
|
133,475
|
$4,012,258 | — | 30 Jun 2023 |
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) as of Q3 2023
As of 30 Sep 2023,
SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) was held by
235 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,959,606 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, MACQUARIE GROUP LTD, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, LOOMIS SAYLES & CO L P, Stephens Investment Management Group LLC, Polar Capital Holdings Plc, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
235
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
244
Q3 2023 holders
235
Holder diff
-9
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.